BioWorld

May 13, 2002

View Archived Issues

ViroPharma Prepares To Receive Not Approvable' Picovir Letter

The FDA is not expected to grant ViroPharma Inc. regulatory clearance for its cold medicine that has been criticized for reducing the duration of illness by only one day. (BioWorld Today) Read More

Wyeth Stops Heart Attack Study; Neose Loses Manufacturing Deal

Read More

TIGR Deploys Sequence-Based Genomic Analyses To Compare Suspect Anthrax Strain Variants

Read More

Isotechnika, Roche To Focus On Transplantation; RA Trial Delayed

Read More

Other News To Note

Read More

Gliatech Files For Chapter 11 Following Product Setbacks

Read More

U.S. Patent Disclosures

Read More